Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition

Ivette M. Sosa Seda, Justin L. Mott, Yuko Akazawa, Fernando J. Barreyro, Steven F. Bronk, Scott H. Kaufmann, Gregory J. Gores

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim: Induction of hepatic stellate cell (HSC) apoptosis is a viable therapeutic strategy to reduce liver fibrogenesis. Although BH3-only proteins of the Bcl-2 family trigger pro-apoptotic pathways, the BH3-only proteins mediating HSC apoptosis have not been well defined. Our aim, using proteasome inhibition as a model to induce HSC apoptosis, was to examine the BH3-only proteins contributing to cell death of this key liver cell subtype. Methods: Apoptosis was induced by treating LX-2 cells, an immortalized human hepatic stellate cell line, and primary rat stellate cells with the proteasome inhibitor MG-132. Results: Treatment with proteasome inhibitors increased expression of Noxa both at the mRNA (16-fold) and protein (22-fold) levels indicating that both transcriptional and post-translational mechanisms contributed to the increase in cellular Noxa levels. Knockdown of Noxa by siRNA significantly attenuated cell death, mechanistically implicating Noxa as a key apoptotic mediator of proteasome inhibitor-induced cell death. Given the pivotal role for the anti-apoptotic Bcl-2 protein A1 in activated HSC survival, we determined if Noxa bound to this survival protein. Noxa was shown to physically bind the anti-apoptotic Bcl-2 protein A1 by co-immunoprecipitation. Conclusions: Noxa contributes to proteasome inhibitor-induced apoptosis of stellate cells likely by binding A1. Strategies to therapeutically increase Noxa expression may be useful for inducing HSC apoptosis.

Original languageEnglish (US)
Pages (from-to)701-710
Number of pages10
JournalHepatology Research
Volume40
Issue number7
DOIs
StatePublished - Jul 1 2010

Fingerprint

Noxae
Hepatic Stellate Cells
Proteasome Endopeptidase Complex
Apoptosis
Proteasome Inhibitors
Proteins
Cell Death
Liver
Immunoprecipitation
Small Interfering RNA
Cell Survival
Cell Line
Messenger RNA
Survival

Keywords

  • BCL2-related protein A1
  • BH3-only proteins
  • Bfl-1
  • Fibrosis
  • PMAIP1
  • S-peptide

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases

Cite this

Sosa Seda, I. M., Mott, J. L., Akazawa, Y., Barreyro, F. J., Bronk, S. F., Kaufmann, S. H., & Gores, G. J. (2010). Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition. Hepatology Research, 40(7), 701-710. https://doi.org/10.1111/j.1872-034X.2010.00668.x

Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition. / Sosa Seda, Ivette M.; Mott, Justin L.; Akazawa, Yuko; Barreyro, Fernando J.; Bronk, Steven F.; Kaufmann, Scott H.; Gores, Gregory J.

In: Hepatology Research, Vol. 40, No. 7, 01.07.2010, p. 701-710.

Research output: Contribution to journalArticle

Sosa Seda, IM, Mott, JL, Akazawa, Y, Barreyro, FJ, Bronk, SF, Kaufmann, SH & Gores, GJ 2010, 'Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition', Hepatology Research, vol. 40, no. 7, pp. 701-710. https://doi.org/10.1111/j.1872-034X.2010.00668.x
Sosa Seda, Ivette M. ; Mott, Justin L. ; Akazawa, Yuko ; Barreyro, Fernando J. ; Bronk, Steven F. ; Kaufmann, Scott H. ; Gores, Gregory J. / Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition. In: Hepatology Research. 2010 ; Vol. 40, No. 7. pp. 701-710.
@article{faf063fabdd44c7f86acd3e7537a9a7e,
title = "Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition",
abstract = "Aim: Induction of hepatic stellate cell (HSC) apoptosis is a viable therapeutic strategy to reduce liver fibrogenesis. Although BH3-only proteins of the Bcl-2 family trigger pro-apoptotic pathways, the BH3-only proteins mediating HSC apoptosis have not been well defined. Our aim, using proteasome inhibition as a model to induce HSC apoptosis, was to examine the BH3-only proteins contributing to cell death of this key liver cell subtype. Methods: Apoptosis was induced by treating LX-2 cells, an immortalized human hepatic stellate cell line, and primary rat stellate cells with the proteasome inhibitor MG-132. Results: Treatment with proteasome inhibitors increased expression of Noxa both at the mRNA (16-fold) and protein (22-fold) levels indicating that both transcriptional and post-translational mechanisms contributed to the increase in cellular Noxa levels. Knockdown of Noxa by siRNA significantly attenuated cell death, mechanistically implicating Noxa as a key apoptotic mediator of proteasome inhibitor-induced cell death. Given the pivotal role for the anti-apoptotic Bcl-2 protein A1 in activated HSC survival, we determined if Noxa bound to this survival protein. Noxa was shown to physically bind the anti-apoptotic Bcl-2 protein A1 by co-immunoprecipitation. Conclusions: Noxa contributes to proteasome inhibitor-induced apoptosis of stellate cells likely by binding A1. Strategies to therapeutically increase Noxa expression may be useful for inducing HSC apoptosis.",
keywords = "BCL2-related protein A1, BH3-only proteins, Bfl-1, Fibrosis, PMAIP1, S-peptide",
author = "{Sosa Seda}, {Ivette M.} and Mott, {Justin L.} and Yuko Akazawa and Barreyro, {Fernando J.} and Bronk, {Steven F.} and Kaufmann, {Scott H.} and Gores, {Gregory J.}",
year = "2010",
month = "7",
day = "1",
doi = "10.1111/j.1872-034X.2010.00668.x",
language = "English (US)",
volume = "40",
pages = "701--710",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition

AU - Sosa Seda, Ivette M.

AU - Mott, Justin L.

AU - Akazawa, Yuko

AU - Barreyro, Fernando J.

AU - Bronk, Steven F.

AU - Kaufmann, Scott H.

AU - Gores, Gregory J.

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Aim: Induction of hepatic stellate cell (HSC) apoptosis is a viable therapeutic strategy to reduce liver fibrogenesis. Although BH3-only proteins of the Bcl-2 family trigger pro-apoptotic pathways, the BH3-only proteins mediating HSC apoptosis have not been well defined. Our aim, using proteasome inhibition as a model to induce HSC apoptosis, was to examine the BH3-only proteins contributing to cell death of this key liver cell subtype. Methods: Apoptosis was induced by treating LX-2 cells, an immortalized human hepatic stellate cell line, and primary rat stellate cells with the proteasome inhibitor MG-132. Results: Treatment with proteasome inhibitors increased expression of Noxa both at the mRNA (16-fold) and protein (22-fold) levels indicating that both transcriptional and post-translational mechanisms contributed to the increase in cellular Noxa levels. Knockdown of Noxa by siRNA significantly attenuated cell death, mechanistically implicating Noxa as a key apoptotic mediator of proteasome inhibitor-induced cell death. Given the pivotal role for the anti-apoptotic Bcl-2 protein A1 in activated HSC survival, we determined if Noxa bound to this survival protein. Noxa was shown to physically bind the anti-apoptotic Bcl-2 protein A1 by co-immunoprecipitation. Conclusions: Noxa contributes to proteasome inhibitor-induced apoptosis of stellate cells likely by binding A1. Strategies to therapeutically increase Noxa expression may be useful for inducing HSC apoptosis.

AB - Aim: Induction of hepatic stellate cell (HSC) apoptosis is a viable therapeutic strategy to reduce liver fibrogenesis. Although BH3-only proteins of the Bcl-2 family trigger pro-apoptotic pathways, the BH3-only proteins mediating HSC apoptosis have not been well defined. Our aim, using proteasome inhibition as a model to induce HSC apoptosis, was to examine the BH3-only proteins contributing to cell death of this key liver cell subtype. Methods: Apoptosis was induced by treating LX-2 cells, an immortalized human hepatic stellate cell line, and primary rat stellate cells with the proteasome inhibitor MG-132. Results: Treatment with proteasome inhibitors increased expression of Noxa both at the mRNA (16-fold) and protein (22-fold) levels indicating that both transcriptional and post-translational mechanisms contributed to the increase in cellular Noxa levels. Knockdown of Noxa by siRNA significantly attenuated cell death, mechanistically implicating Noxa as a key apoptotic mediator of proteasome inhibitor-induced cell death. Given the pivotal role for the anti-apoptotic Bcl-2 protein A1 in activated HSC survival, we determined if Noxa bound to this survival protein. Noxa was shown to physically bind the anti-apoptotic Bcl-2 protein A1 by co-immunoprecipitation. Conclusions: Noxa contributes to proteasome inhibitor-induced apoptosis of stellate cells likely by binding A1. Strategies to therapeutically increase Noxa expression may be useful for inducing HSC apoptosis.

KW - BCL2-related protein A1

KW - BH3-only proteins

KW - Bfl-1

KW - Fibrosis

KW - PMAIP1

KW - S-peptide

UR - http://www.scopus.com/inward/record.url?scp=77954749581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954749581&partnerID=8YFLogxK

U2 - 10.1111/j.1872-034X.2010.00668.x

DO - 10.1111/j.1872-034X.2010.00668.x

M3 - Article

C2 - 20557369

AN - SCOPUS:77954749581

VL - 40

SP - 701

EP - 710

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 7

ER -